Geron Corporation - Common Stock — Balance Sheet (NASDAQ:GERN) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 270.73 M226.03 M190.57 M394.08 M593.78 M570.54 M Total liabilities 59.78 M99.62 M110.58 M146.13 M313.46 M344.67 M Total equity 210.95 M126.42 M80 M247.95 M280.32 M225.87 M Total liabilities & shareholders' equities 270.73 M226.03 M190.57 M394.08 M593.78 M570.54 M Total debt 24.04 M49.83 M51.16 M81.94 M165.37 M119.55 M Net debt 24.04 M49.83 M51.16 M81.94 M165.37 M119.55 M

News

Geron Corporation: Commercial Performance Could Dovetail With IMpactMF Run-Up (GERN)

Myriad (MYGN) Soars 8.3%: Is Further Upside Left in the Stock?

Geron Corporation (GERN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

After Plunging 26.6% in 4 Weeks, Here's Why the Trend Might Reverse for Geron (GERN)

Geron: Time To Reconsider This Oversold Biotech (NASDAQ:GERN)

Geron (GERN) Loses 21.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Geron Corporation (GERN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Geron (GERN) Reports Q1 Loss, Beats Revenue Estimates

Geron at Barclays Healthcare Conference: Strategic Growth and Future Plans

Geron Corporation (GERN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?

Geron at TD Cowen: Strategic Growth and Market Expansion